Pfizer Accused Of Illegally Inflating Epilepsy Drug Price In UK
Britain's antitrust watchdog said Thursday it has provisionally found that Pfizer and Flynn have broken competition law by exploiting a loophole to raise the price that the NHS and pharmacies paid...To view the full article, register now.
Already a subscriber? Click here to view full article